Top compounds associated with response to LGR5


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.08
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.057 0.08
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.067 0.08
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.063 0.08
mRNA AR-42 GDSC1000 pan-cancer AAC 0.055 0.08
mRNA AMG-706 GDSC1000 pan-cancer AAC -0.064 0.08
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.065 0.08
mRNA CP724714 GDSC1000 pan-cancer AAC -0.06 0.08
mRNA AS605240 GDSC1000 pan-cancer AAC 0.059 0.08
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.08
Download CSV